Table 5.

eGFR and UP/C levels at weeks 0, 26, 52, and 78 in 20 patients responding to MMF/DEX

WeekeGFR and UP/C LevelChange (wk)% Change in eGFR and UP/C
eGFR mean ± SD (ml/min per 1.73 m2)UP/C median (10th–90th percentiles) (mg/mg)eGFR mean ± SD (%)P ValueUP/C median (10th–90th percentiles) (%)P Value
0122.6±50.73.6 (1.1–9.6)0–26+0.8±23.10.88−76.2 (−91.9 to −59.7)<0.001
26119.7±46.30.8 (0.2–1.5)0–52+7.0±25.70.24−82.7 (−97.0 to −30.4)<0.001
52128.9±57.00.5 (0.1–2.6)0–78+3.8±28.50.56−80.3 (−94.5 to −0.7)<0.001
78126.1±58.90.8 (0.1–3.3)52–78−2.6±16.60.50+25.0 (−50.2 to 268.3)0.06
  • MMF/DEX, mycophenolate mofetil/dexamethasone; eGFR, estimated GFR; UP/C, urinary protein/creatinine.